baber/WOPTO huggingface dataset:
Patent AU-2017219795-A1 (AU)
Title: Terminal Apparatus, Mobility Management Entity (MME), and Communication Control Method
Inventor: KAWASAKI Yudai
IPC: H04W8/02
Filed: 2017-02-15
Abstract: This communications control method for a terminal device has a step in which an attachment acceptance message including at least first identification information and/or second identification information is received from a core network via a base station device, said first identification information indicating mobility types supported by the core network and said second identification information indicating mobility types permitted for the core network. As a result, suitable communications procedures for determining the mobility type of a terminal are provided.
Patent AU-2017250663-A1 (AU)
Title: Detecting pancreatic high-grade dysplasia
Inventor: AHLQUIST DAVID A
IPC: C12Q1/68
Filed: 2017-04-13
Abstract: Provided herein is technology for pancreatic high-grade dysplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of pancreatic high-grade dysplasia (IPMN-HGD, PanIN-3, or PDAC).
Patent AU-2017253621-A1 (AU)
Title: Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia
Inventor: ZUGMAIER GERHARD
IPC: C07K16/28
Filed: 2017-04-18
Abstract: The present invention provides a bispecific construct comprising a first binding domain specifically binding to CD33 and a second binding domain specifically binding to CD3 for use in a method for the treatment of myeloid leukemia, wherein the construct is administered for a maximal period of 14 days followed by a period of at least 14 days without administration of the construct. Moreover, the invention provides a method for the treatment of myeloid leukemia comprising the administration of a therapeutically efficientamount of such bispecific construct and the use of such bispecific construct for the preparation of a pharmaceutical composition for the treatment of myeloid leukemia.
Patent AU-2017258890-A1 (AU)
Title: Cleaning device
Inventor: REEVES MARK
IPC: A47L9/10
Filed: 2017-11-09
Abstract: CLEANING DEVICE A vacuum cleaner comprises a housing and a motor fan assembly arranged to generate an air flow. A detachable dirt container is mountable to the housing and the dirt container has a dirty air inlet in fluid communication with the motor fan assembly. A filter is for separating dirt from the air flow and the filter is mounted 5 between the dirt container and the motor fan assembly. Wherein the detachable dirt container comprises an emptying aperture in a wall of the dirt container, the emptying aperture being downstream in the air flow from the dirty air inlet and upstream of the filter. Wherein the housing comprises an overlap portion for covering the emptying aperture in the dirt container and sealing the emptying aperture when the detachable 10 dirt container is mounted to the housing. Figure 2 C\J C\J C\J C\ C)\ C\J CO
Patent AU-2017272349-A1 (AU)
Title: Therapeutic recombinant klotho proteins and compositions and methods involving the same
Inventor: TARSIO JOSEPH F
IPC: A61K38/22
Filed: 2017-06-02
Abstract: Recombinant Klotho proteins and variants, nucleic acids encoding the same, cell lines and suspension cultures expressing the same, and method of manufacturing and administering the same are disclosed. Proteins include solubility or half-life-extending features like glycosylation and fusion protein tags. Proteins have at least 85% amino acid sequence identity to a portion of human alpha Klotho isoform 1. Treatment protocols include determining serum soluble Klotho level in a subject, calculating a dosage of the protein sufficient to raise the serum soluble Klotho level in the subject to a predetermined level, administering the dosage of protein to the subject, such as by bolus or gradual injection, determining a rate of Klotho protein decline in the serum of the subject following administration of the first dosage, calculating a time and amount of a subsequent dosage of the Klotho protein, and administering the subsequent dosage of Klotho protein to the subject.
Patent AU-2017275862-A1 (AU)
Title: Arthroscope
Inventor: SICCARDI FRANCESCO
IPC: G02B23/24
Filed: 2017-05-17
Abstract: An arthroscope (1) comprises a sleeve (20) having an internally hollow, proximal portion (21 ) suitable to be at least partially positioned in contact with the body of a patient and an internally hollow middle portion (22) connected to the proximal portion (21) so as to create a through axial cavity. The sleeve (20) has, within the middle portion (22), an abutment area (27). The arthroscope also comprises an optical unit (10) having an elongated portion (11) and a coupling portion (12) suitable to be at least partially received inside the through axial cavity of the sleeve (20). The coupling portion (12) has a matching area (17) suitable to couple with the abutment area (27). The matching area (17) and the abutment area (27) are shaped so as to have at least one pilot element (17.1, 27.1) so as to determine a univocal predefined coupling position between the sleeve (20) and the optical unit (10); the matching area (17) and the abutment area (27) are also shaped so as to guide and automatically place the optical unit (10) in such a predefined position.
Patent AU-2017301881-A1 (AU)
Title: Methods for assessing the presence or absence of replication competent virus
Inventor: BIANCHI ALLISON ADIN
IPC: C12Q1/70
Filed: 2017-07-28
Abstract: Provided are methods of detecting replication competent retrovirus in a sample containing a cell transduced with a viral vector particle encoding a recombinant and/or heterologous molecule, e.g., heterologous gene product. The methods may include assessing transcription of one or more target genes, such as viral genes, that are expressed in a retrovirus but not expressed in the viral vector particle. Replication competent retrovirus may be determined to be present if the levels of RNA of the one or more target genes is higher than a reference value, which can be measured directly or indirectly, including from a positive control sample containing RNA from the respective target gene at a known level and/or at or above the limit of detection of the assay.
Patent AU-2017306409-A1 (AU)
Title: Mooring system for drifting energy converters
Inventor: Sheldon-Coulson Garth Alexander
IPC: F03B13/12
Filed: 2017-08-02
Abstract: A system that maintains the relative and/or absolute geographical positions of two or more buoyant devices floating in a body of water. A plurality of formation restoring tethers are disclosed which permit the unrestricted vertical movement of networked buoyant devices, while resisting increases in their lateral separations by providing restoring forces to oppose such separations. Tensioning mechanisms incorporated into the tethers generate the resistance to the lateral separations of two or more entities by transforming such separations into an increase in the potential energy stored within such tensioning mechanisms, the potential energy of which is released in the process of restoring the original separations and/or positions of the displaced buoyant devices.
Patent AU-2017313039-A1 (AU)
Title: Selecting and dispensing blended beverages from a post-mix beverage dispenser
Inventor: SCHWARBER JOSHUA
IPC: G07F13/06
Filed: 2017-08-15
Abstract: A system and method for creating a mixed consumable item may include displaying a first set of selectable indicia on a touchscreen, where the indicia may be (i) indicative of respective consumable ingredients and (ii) distinctly positioned relative to one another. A swype gesture may be received from a user via the touchscreen that forms a path extending between a first position and a second position that touches or passes close to multiple selectable indicia. From the first set of consumable ingredients, a plurality of combinations of consumable ingredients most likely to have been intended to be selected by the user based on the path of the swype gesture may be predicted. Selectable predicted combinations of consumable ingredients may be displayed on the touchscreen to enable one of the selectable combinations of consumable ingredients to be selected by the user for mixing by a dispenser of consumable items.
Patent AU-2017326003-A1 (AU)
Title: KLRG1 depletion therapy
Inventor: GREENBERG STEVEN
IPC: A61K39/395
Filed: 2017-09-15
Abstract: A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1) depleting agent, thereby depleting CD8+ cytotoxic T and/or NK cells in vivo. A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a KLRG1 depleting agent with effector killing function. A composition, for example an anti-KLRG1 antibody, can comprise a KLRG1 depleting agent. The methods and compositions can be used for various diseases in which KLRG1 is overexpressed, for example autoimmune diseases, transplant rejection, hematologic malignancies, and solid tumors.
Patent AU-2017339433-A1 (AU)
Title: Systems and methods for language detection
Inventor: BOJJA NIKHIL
IPC: G06F17/27
Filed: 2017-10-02
Abstract: Implementations of the present disclosure are directed to a method, a system, and a computer program storage device for identifying a language in a message. Non-language characters are removed from a text message to generate a sanitized text message. An alphabet and/or a script are detected in the sanitized text message by performing at least one of (i) an alphabet-based language detection test to determine a first set of scores and (ii) a script-based language detection test to determine a second set of scores. Each score in the first set of scores represents a likelihood that the sanitized text message includes the alphabet for one of a plurality of different languages. Each score in the second set of scores represents a likelihood that the sanitized text message includes the script for one of the plurality of different languages. The language in the sanitized text message is identified based on at least one of the first set of scores, the second set of scores, and a combination of the first and second sets of scores.
Patent AU-2017348074-A1 (AU)
Title: Direct numerical simulation of petrophysical properties of rocks with two or more immicible phases
Inventor: FREDRICH JOANNE
IPC: G06T7/62
Filed: 2017-10-25
Abstract: A method for analyzing a rock sample includes segmenting a digital image volume corresponding to the rock sample, to associate voxels in the digital image volume with pore space or solid material. A distance transform is applied to each pore space voxel. The distance transform assigns a distance value to the pore space voxel specifying distance from the pore space voxel to a solid material voxel. Drainage is numerically simulated by, for a pore space, selecting each distance value assigned to a pore space voxel that is greater than a predetermined threshold value to represent a radius of a sphere of a non-wetting fluid introduced into the pore space. The sphere is centered at the pore space voxel corresponding to the distance value. The digital image volume is numerically analyzed to characterize a material property of the rock sample at a non-wetting fluid saturation produced by the drainage.
Patent AU-2017361887-A1 (AU)
Title: Anti-GP73 antibodies and immunoconjugates
Inventor: STENNER-LIEWEN FRANK
IPC: C07K16/18
Filed: 2017-11-21
Abstract: The present invention relates to antigen-binding molecules, preferably antibodies or antigen-binding fragments thereof, that specifically bind to a GP73, or to an antigenic portion thereof, wherein the antigen-binding molecule binds to an epitope within the extracellular part of GP73 that is internalized into a cell usually subsequent to proteolytic cleavage. The invention further relates to immunoconjugates comprising the antigen-binding molecules, in particular the anti-GP73 antibodies, or antigen-binding fragments thereof. The antigen- binding molecules and immunoconjugates of the invention may be administered alone, as a therapeutic conjugate or in combination with other naked antibodies, or with therapeutic agents, or with other immunoconjugates or as a diagnostic conjugate. The present invention also relates to nucleotide sequences encoding anti GP73 antibodies, and immunoconjugates, vectors and host cells containing the nucleotide sequences, and methods of making anti-GP73-antibodies. The antigen-binding molecules, antibodies and compositions of the invention are useful in diagnostic and therapeutic applications for diseases in which expression of GP73 is altered, in particular in which GP73 is overexpressed, such as cancer.
Patent AU-2017362324-A1 (AU)
Title: Subsea flange tool
Inventor: WRIGHT DAVID C
IPC: B23P19/06
Filed: 2017-11-15
Abstract: A torqueing tool for rotating bolts connecting a pipe flange in a subsea environment, comprising a first guide for guiding movement of the torqueing along a pipe, a socket for engaging a first bolt, a shaft for transferring torque from a motor to the socket, and a first protruding member for insertion between the pipe and a second bolt of the pipe flange, to prevent the torqueing tool from rotating due to counter torque created while applying torque to the first fastener. The torqueing tool can further comprise a second protruding member adjacent the socket, wherein the second protruding member can be inserted between the pipe and a third bolt of the pipe flange. The torqueing tool can further comprise an angled shaft for transferring torque from the motor to the socket, wherein an axis of rotation of the motor is different from an axis of rotation of the socket.
Patent AU-2017371507-A1 (AU)
Title: Cationic nanoparticles for enhancing infectious capacity of live viruses
Inventor: BETBEDER DIDIER
IPC: C12N15/86
Filed: 2017-12-11
Abstract: The present invention relates to a combination of cationic nanoparticles and viruses and uses thereof. The invention particularly relates to the use of nanoparticles for enhancing the infectious capacity of a live virus, preferably a non-enveloped live virus.
Patent AU-2017378044-A1 (AU)
Title: Method of preparing benzyl 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)picolinate
Inventor: FISK JASON S
IPC: C07D213/79
Filed: 2017-12-06
Abstract: A method of preparing benzyl 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)picolinate (I) from benzyl 4,5-difluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)picolinate (II) is described. The method includes the use of amination and chlorination process steps to provide the compound of Formula I.
Patent AU-2017387765-A1 (AU)
Title: Kernel event triggers
Inventor: von Muhlen Marcio
IPC: G06F9/54
Filed: 2017-11-02
Abstract: The present technology pertains to responding to a kernel level file event for a content item and presenting a file event window associated with the content item. A client device can detect the kernel level file event for the content item. This can be accomplished using a kernel extension on a client device that is networked with a content management system. The client device can then retrieve data associated with the content item, including an instruction for the content item. The client device can then perform the instruction. This instruction can be to retrieve collaboration data from the content management system and present the collaboration data in a file event window.
Patent AU-2017422275-A1 (AU)
Title: Absorbent article and method for manufacturing an absorbent article
Inventor: Rönnberg Peter
IPC: A61F13/56
Filed: 2017-07-07
Abstract: The present invention relates to an absorbent article (1) comprising a main body (2) having a liquid-permeable topsheet (3), a liquid-impermeable backsheet (4) and an absorbent core (5) sandwiched between said topsheet (3) and said backsheet (4), said main body (2) being arranged along a longitudinal axis (Y1) and a transversal axis (X1) extending in a perpendicular direction in relation to the longitudinal axis (Y1), said main body (2) defining a front portion (6), a back portion (7) and a crotch portion (8); wherein said article (1) comprises a first wing (9) and a second wing (10) extending outwardlyfrom said crotch portion (8) of the main body (2) in opposite directions in an asymmetric manner with reference to the longitudinal axis (Y1), and generally along said transversal axis(X1), said wings (9, 10) being provided with fastening means (11, 12) configured for fastening said wings (9, 10) to a garment when being folded over said main body (2) and towards said longitudinal axis (Y1). Furthermore, each wing has a first edge section (20) extending generally along a first straight line (20a) and a second edge section (21) extending generally along a second straight line (21a), wherein the first line (20a) defines a first angle (α2) with respect to the longitudinal axis (Y1) and wherein the second line (21a) defines a second angle (α3) with respect to the longitudinal axis (Y1), the magnitude of said angles (α2, α3) being chosen so that α2<α3.The invention also relates to a method for manufacturing an absorbent article (1) of the above-mentioned type.
Patent WO-2019046883-A1 (WO)
Title: Encapsulation system and method of installing a rock bolt
Inventor: EVANS DAVID WILLIAM
IPC: E21D20/02
Filed: 2018-09-07
Abstract: An encapsulation system (100) for use in securing a rock bolt in a bore hole drilled into a rock face to be stabilised, said encapsulation system comprising at least two separate encapsulation mediums (112,122) and one or more elongate cartridges (110,120) containing said encapsulation mediums (112,122), each said cartridge having a frangible casing (111,121), said encapsulation mediums including: a first encapsulation medium (112) comprising a curable first resin formulation; and a second encapsulation medium (122); wherein, following use in securing a rock bolt, said second encapsulation medium has a lower bond strength and/or a lower compressive strength than said first resin formulation.
Patent WO-2019046912-A1 (WO)
Title: Binding proteins to the human thrombin receptor, par4
Inventor: HAMILTON JUSTIN
IPC: A61P7/02
Filed: 2018-09-11
Abstract: The present disclosure is directed to human protease activated receptor 4 (PAR4) binding proteins (e.g. antibodies). In particular, anti-PAR4 binding proteins which are antagonists of human PAR4, as well as methods and uses thereof.
Patent AU-2018200668-A1 (AU)
Title: Composition for solubilizing target protein and use thereof
Inventor: LEE JUN HYOUNG
IPC: C07K14/00
Filed: 2018-01-29
Abstract: Provided are a composition for solubilizing a target protein, including an expression cassette including a promoter and a gene encoding a fusion protein of a chaperone and an RNA-binding domain or an expression vector including the expression cassette; a transformant including the expression cassette or the expression vector; a kit including the composition or the transformant; and a method for producing the target protein by using the same. a b •Soluble fraction •Insoluble fraction refold or transfer 90 96 toher chaperones 8 DnaJ or DnaK a or DnaJ-DnaK 0 correctly fodedprotein 0 mis-folded protein - G40 G4S linker KH3 domain 30 ProeiN -j 20 KHbinding 10 hairpin 5'. 3 C mRAribosomesae rQ KH binding hairi n g-- d m Soluble fraction nInsoluble fraction a 0 - c 30 5' --a g a 3 0 ?-c 60A 500 0 g-c 40 5 -- 30 g-c ~OA4 j20 spacer c <>~0& 1Iloop design 3 loops design DnaJK-KH + + + N KH binding hairpin - + - .+ f 25000 complemented sfGFP C-sfGFP correctly-folded 20000 emits fluorescence / soule -sTF (soluble) 15000 mis-folded N-sfGFP 5000 (insoluble) LL. 5. U ~D§Dna K 0 " KH domain 511DnaJK-KH- - - - - + + N-sfGFP mRNA 3X KI-binding KH binding hairpin - - - + - + hairpins Figure 1
Patent AU-2018219365-A1 (AU)
Title: Multikinase inhibitors of VEGF and TGF beta and uses thereof
Inventor: TANG-LIU DIANE
IPC: A61K31/505
Filed: 2018-02-12
Abstract: A pharmaceutical composition for prevention or treatment of a disease or disorder characterized by chronic inflammation, with associated angiogenesis and fibrosis, wherein the disease or disorder is selected from the group consisting of rosacea, psoriasis, erythema multiforme, bullous pemphigoid, hereditary hemorrhagic telangiectasia, rheumatoid arthritis, atopic dermatitis, and dermal wound healing. The pharmaceutical composition includes at least one multi-kinase inhibitor selected from the group consisting of axitinib, nintedanib, and lenvatinib.
Patent AU-2018230440-A1 (AU)
Title: Performing a calibration process in a quantum computing system
Inventor: BLOOM BENJAMIN JACOB
IPC: B82Y10/00
Filed: 2018-03-09
Abstract: In a general aspect, calibration is performed in a quantum computing system. In some cases, domains of a quantum computing system are identified, where the domains include respective domain control subsystems and respective subsets of quantum circuit devices in a quantum processor of the quantum computing system. Sets of measurements are obtained from one of the domains and stored in memory. Device characteristics of the quantum circuit devices of the domain are obtained based on the set of measurements, and the device characteristics are stored in a memory of the control system. Quantum logic control parameters for the subset of quantum circuit devices of the domain are obtained based on the set of measurements and stored in memory.
Patent AU-2018246009-A1 (AU)
Title: Surface for directional fluid transport including against external pressure
Inventor: GOEDERS KAREN M
IPC: F04F7/00
Filed: 2018-03-22
Abstract: A capillary structure for passive, directional fluid transport, includes a capillary having a forward direction and a backward direction extending in an x-y plane and a depth extending in a z-direction, the capillary including first and second capillary units each having a diverging section having a backward end, a forward end, and a width in the y-direction, wherein the width increases from the backward end to the forward end, wherein the backward end of the second capillary unit diverging section is connected to the forward end of the first capillary unit diverging section to form a transition section having a step decrease in width from the forward end of the first capillary unit diverging section to the backward end of the second capillary unit diverging section, and wherein the depth in the transition section is less than the depth in each diverging section.
Patent AU-2018255488-A1 (AU)
Title: Fertiliser coating composition
Inventor: SMITH BRADLEY JOHN
IPC: C05G3/60
Filed: 2018-04-19
Abstract: A coating composition for applying a poorly water-soluble active compound to granules of a fertiliser, the coating composition comprising an emulsion comprising an aqueous phase and a non-aqueous phase, wherein the poorly water-soluble active compound is suspended in the aqueous phase, and a water-soluble adhesive agent is dissolved in the aqueous phase.
Patent AU-2018264055-A1 (AU)
Title: Uv protective compositions and their use
Inventor: LANDA BENZION
IPC: A61K8/02
Filed: 2018-11-14
Abstract: LIP 3/009 AU DIV Disclosed are UV-protective compositions comprising Fe-doped zinc titanate having the general formula Zn2Tiix)FexO 4, wherein x is between 0.005 and 0.1. Also disclosed is Fe-doped or undoped zinc titanate being either directly dispersed in the composition and/or dispersed in a polymer matrix. Methods of preparation and uses of such compositions are also provided. CC; w C) 4 CLo C, c CL v %mo rn %- 7 00 r- w. Ln N m r4 C a~u eq~iosqV